Merck to discontinue development of two Covid-19 vaccine candidates
Merck is reportedly discontinuing the development of its SARS-CoV-2 / Covid-19 vaccine candidates, V590 and...
Elasmogen identifies potential vaccine candidates to fight Covid-19
Elasmogen has identified protein-based drugs that can potentially stop Covid-19 infections, through a partnership with...
Telemedicine to benefit the most from remote patient monitoring tools: Poll
The COVID-19 pandemic has led to a surge in the use of remote patient monitoring...
Australia approves Pfizer-BioNTech’s Covid-19 vaccine
Australia’s Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer-BioNTech Covid-19 vaccine for use in...
Turn Therapeutics gets authorisation for Covid-19 therapeutic candidate trial
Biotechnology company Turn Therapeutics has received authorisation in Panama to begin the human trial of...
UAE approves Sputnik V Covid-19 vaccine for emergency use
The Russian Direct Investment Fund has announced that the UAE Ministry of Health and Prevention...
Fire at Serum Institute of India facility kills five people
A fire accident that occurred at the Serum Institute of India’s (SII) facility in the...
Akron Biotech, Octapharma enter Human AB Serum global production deal
Akron Biotech has signed an exclusive global agreement with Switzerland-based Octapharma to produce virally inactivated...
Cross-EU drug supply chain to be most affected post Brexit: Poll
The UK’s decision to opt out of the European Union (EU) has set numerous industries...
Adamis submits IND application to FDA for Covid-19 treatment
Speciality biopharmaceutical company Adamis Pharmaceuticals has submitted an Investigational New Drug (IND) to the US...